Public Health Effects of Xylazine - 11-18-2025
Joint Committee working group on oversight and enforcement (xylazine) · November 18, 2025
A Massachusetts working group convened to examine oversight, regulation, and possible scheduling of xylazine after public testimony about its appearance in the illicit drug supply. Members heard Department of Public Health concerns about scheduling, discussed data sources and veterinary uses, and formed two subgroups to prepare materials for a Dec. 11 public meeting.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No related articles available for this source.
